Published 1 September 2009, doi:10.1136/bmj.b3485
Cite this as: BMJ 2009;339:b3485

Letters

QRISK validation and evaluation

QRISK may be less useful

The first 150 words of the full text of this article appear below.

Collins and Altman inappropriately criticise the National Institute for Health and Clinical Excellence (NICE) for not choosing QRISK to predict cardiovascular risk.1 In doing so, they do not distinguish between assessing individual cardiovascular risk (as used by clinicians) and predicting risk of cardiovascular events in an actively managed population (as used in public health planning). As most tools predicting cardiovascular risk were developed in actively managed populations, they will underestimate the risk that clinicians and patients are initially interested in: the risk if no further treatment is initiated. This distinction seems to be overlooked in most discussion of cardiovascular risk.

Most doctors would expect to explain the risk to patients were they left untreated. As with several other tools, however, QRISK was derived from a population cohort that may start additional treatments once found to have high rates of risk factors. Hence it is not surprising that it underpredicts cardiovascular . . . [Full text of this article]

Su May Liew, research student1, Paul Glasziou, professor1

1 Centre for Evidence-Based Medicine, Department of Primary Health Care, University of Oxford OX3 7LF

su.liew@dphpc.ox.ac.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Authors’ reply
Gary S Collins and Douglas G Altman
BMJ 2009 339: b3516. [Extract] [Full Text]

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
Gary S Collins and Douglas G Altman
BMJ 2009 339: b2584. [Abstract] [Full Text] [PDF]

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study
Julia Hippisley-Cox, Carol Coupland, Yana Vinogradova, John Robson, Margaret May, and Peter Brindle
BMJ 2007 335: 136. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Collins, G. S, Altman, D. G (2009). Authors' reply. BMJ 339: b3516-b3516 [Full text]  

Rapid Responses:

Read all Rapid Responses

Let's make comparisons fair
Bennett N Quinn
bmj.com, 2 Sep 2009 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ